4.7 Article

Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014

期刊

EMERGING INFECTIOUS DISEASES
卷 24, 期 6, 页码 1010-1019

出版社

CENTERS DISEASE CONTROL
DOI: 10.3201/eid2406.171648

关键词

-

资金

  1. John Mung Program from Kyoto University, Japan
  2. Calgary Laboratory Services [10015169]
  3. National Institutes of Health [R01AI090155, R21AI117338]
  4. Genome Center for Infectious Diseases grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases [U19AI110819]
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090155, U19AI110819, R21AI117338] Funding Source: NIH RePORTER

向作者/读者索取更多资源

We performed whole-genome sequencing on 170 clinical carbapenemase-producing Enterobacter spp. isolates collected globally during 2008-2014. The most common carbapenemase was VIM, followed by New Delhi metallo-beta-lactamase (NDM), Klebsiella pneumoniae carbapenemase, oxacillin 48, and IMP. The isolates were of predominantly 2 species (E. xiangfangensis and E. hormaechei subsp. steigerwaltii) and 4 global clones (sequence type [ST] 114, ST93, ST90, and ST78) with different clades within ST114 and ST90. Particular genetic structures surrounding carbapenemase genes were circulating locally in various institutions within the same or between different STs in Greece, Guatemala, Italy, Spain, Serbia, and Vietnam. We found a common NDM genetic structure (NDM-GE-U.S.), previously described on pNDM-U.S. from Klebsiella pneumoniae ATCC BAA-214, in 14 different clones obtained from 6 countries spanning 4 continents. Our study highlights the importance of surveillance programs using whole-genome sequencing in providing insight into the molecular epidemiology of carbapenemase-producing Enterobacter spp.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据